United Therapeutics Corp’s recent filing unveils that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported
United Therapeutics Corp’s recently made public that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
United Therapeutics Corp’s recent filing unveils that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
United Therapeutics Corp’s filing revealed that its EVP & GENERAL COUNSEL MAHON PAUL A unloaded Company’s shares for reported $3.35
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. United Therapeutics